GLP-1 stimulates insulin secretion, inhibits glucagon secretion, slows gastric emptying, and promotes satiety, all of which contribute to weight loss
Consider bringing: A list of your current medications, including your GLP-1 medication, dosage, and how long you have been taking it Any recent lab work (blood glucose, HbA1c, lipid panel, vitamin/mineral panels) A general sense of your current eating patterns (a food diary from the past few days is helpful, but not required) Your eating disorder treatment history, including past diagnoses, treatment programs, and current therapist or treatment team members Any questions you have there are no wrong ones If you feel uncertain about disclosing your eating disorder history, please know that our team works with these complex presentations every day
Wegovy and Blood Clots Overview Wegovy lawsuits claim that Novo Nordisk, the manufacturer of the weight loss drug, failed to warn users about blood clot-related injuries, such as deep vein thrombosis (DVT) and pulmonary embolism
Additionally, the large cardiovascular safety studies did not show a significant respective signal
The time to see results from GLP-1 medications depends on dosage, your bodys response, and your lifestyle choices